NUZ neurizon therapeutics limited

Ann: NUZ-001 Shows Positive Results in Human 3D Brain Model, page-9

  1. 2,998 Posts.
    lightbulb Created with Sketch. 2019
    My Layman's view and some initial research suggests yet another pillar for Neurizon to build upon.



    Conclusion
    In summary, the benefits of neuroplasticity include improved learning, memory, recovery from brain injuries, adaptability with age, and emotional resilience, with potential to assist conditions like stroke, Traumatic Brain Injury, Alzheimer’s, Parkinson’s, MS, depression, anxiety, and learning disabilities. Neurizon’s announcement on April 1, 2025, underscores NUZ-001’s promising pre-clinical results in promoting neuroplasticity, offering hope for ALS and other neurodegenerative diseases, with planned clinical trials in 2025 to validate these findings.


    Lot's more research to do on today's announcement.


    Cheers
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
16.5¢
Change
-0.005(2.94%)
Mkt cap ! $81.23M
Open High Low Value Volume
17.0¢ 17.0¢ 16.5¢ $23.56K 141.5K

Buyers (Bids)

No. Vol. Price($)
3 30232 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 13227 2
View Market Depth
Last trade - 15.37pm 24/06/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.